These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36496472)

  • 1. Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2.
    Machitani M; Takei J; Kaneko MK; Ueki S; Ohashi H; Watashi K; Kato Y; Masutomi K
    Virol J; 2022 Dec; 19(1):213. PubMed ID: 36496472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a new monoclonal antibody against SARS-CoV-2 NSP12 (RdRp).
    Meng W; Guo S; Cao S; Shuda M; Robinson-McCarthy LR; McCarthy KR; Shuda Y; Paniz Mondolfi AE; Bryce C; Grimes Z; Sordillo EM; Cordon-Cardo C; Li P; Zhang H; Perlman S; Guo H; Gao SJ; Chang Y; Moore PS
    J Med Virol; 2023 Jan; 95(1):e28246. PubMed ID: 36271490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 variants with NSP12 P323L/G671S mutations display enhanced virus replication in ferret upper airways and higher transmissibility.
    Kim SM; Kim EH; Casel MAB; Kim YI; Sun R; Kwak MJ; Yoo JS; Yu M; Yu KM; Jang SG; Rollon R; Choi JH; Gil J; Eun K; Kim H; Ensser A; Hwang J; Song MS; Kim MH; Jung JU; Choi YK
    Cell Rep; 2023 Sep; 42(9):113077. PubMed ID: 37676771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 NSP12 utilizes various host splicing factors for replication and splicing regulation.
    Yang L; Zeng XT; Luo RH; Ren SX; Liang LL; Huang QX; Tang Y; Fan H; Ren HY; Zhang WJ; Zheng YT; Cheng W
    J Med Virol; 2024 Jan; 96(1):e29396. PubMed ID: 38235848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutations at specific sites of the nsp12-nsp8 interface dramatically affect the RNA polymerization activity of SARS-CoV-2.
    Ferrer-Orta C; Vázquez-Monteagudo S; Ferrero DS; Martínez-González B; Perales C; Domingo E; Verdaguer N
    Proc Natl Acad Sci U S A; 2024 Jul; 121(29):e2317977121. PubMed ID: 38990941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against
    Naidu SAG; Mustafa G; Clemens RA; Naidu AS
    J Diet Suppl; 2023; 20(2):254-283. PubMed ID: 34850656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates.
    Ahn DG; Choi JK; Taylor DR; Oh JW
    Arch Virol; 2012 Nov; 157(11):2095-104. PubMed ID: 22791111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay.
    Bai X; Sun H; Wu S; Li Y; Wang L; Hong B
    Front Immunol; 2022; 13():844749. PubMed ID: 35464436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis.
    Guo S; Lei X; Chang Y; Zhao J; Wang J; Dong X; Liu Q; Zhang Z; Wang L; Yi D; Ma L; Li Q; Zhang Y; Ding J; Liang C; Li X; Guo F; Wang J; Cen S
    Signal Transduct Target Ther; 2022 Dec; 7(1):400. PubMed ID: 36575184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of natural polymorphisms in SARS-CoV-2 RNA-dependent RNA polymerase on its activity and sensitivity to inhibitors in vitro.
    Miropolskaya N; Kozlov M; Petushkov I; Prostova M; Pupov D; Esyunina D; Kochetkov S; Kulbachinskiy A
    Biochimie; 2023 Mar; 206():81-88. PubMed ID: 36252889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP enhances the error-prone ribonucleotide incorporation by the SARS-CoV-2 RNA polymerase.
    Pourfarjam Y; Ma Z; Kim IK
    Biochem Biophys Res Commun; 2022 Oct; 625():53-59. PubMed ID: 35947915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized Recombinant Expression and Purification of the SARS-CoV-2 Polymerase Complex.
    Podadera A; Campo L; Rehman F; Kolobaric N; Zutic A; Ng KK
    Curr Protoc; 2024 Mar; 4(3):e1007. PubMed ID: 38511495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fidelity of Ribonucleotide Incorporation by the SARS-CoV-2 Replication Complex.
    Yin X; Popa H; Stapon A; Bouda E; Garcia-Diaz M
    J Mol Biol; 2023 Mar; 435(5):167973. PubMed ID: 36690070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
    Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking.
    Elghoneimy LK; Ismail MI; Boeckler FM; Azzazy HME; Ibrahim TM
    Comput Biol Med; 2021 Jul; 134():104468. PubMed ID: 34015671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast and efficient purification of SARS-CoV-2 RNA dependent RNA polymerase complex expressed in Escherichia coli.
    Madru C; Tekpinar AD; Rosario S; Czernecki D; Brûlé S; Sauguet L; Delarue M
    PLoS One; 2021; 16(4):e0250610. PubMed ID: 33914787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent.
    te Velthuis AJ; Arnold JJ; Cameron CE; van den Worm SH; Snijder EJ
    Nucleic Acids Res; 2010 Jan; 38(1):203-14. PubMed ID: 19875418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4
    Westphal T; Mader M; Karsten H; Cords L; Knapp M; Schulte S; Hermanussen L; Peine S; Ditt V; Grifoni A; Addo MM; Huber S; Sette A; Lütgehetmann M; Pischke S; Kwok WW; Sidney J; Schulze Zur Wiesch J
    Front Immunol; 2023; 14():1182504. PubMed ID: 37215095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12).
    Ruan Z; Liu C; Guo Y; He Z; Huang X; Jia X; Yang T
    J Med Virol; 2021 Jan; 93(1):389-400. PubMed ID: 32579254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.